NA
Nishant Amilal Shah
About Nishant Amilal Shah
Data last updated:
Nishant Amilal Shah has 5 years in corporate governance. Holds Designated Partner and Director roles. Currently with 6 companies, including Jackstien International Llp and Affinisio Technologies Llp. Engaged in General Business, Technology and more. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹1,454 Cr; the largest is Thyrocare Technologies Limited at ₹702 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Jun 2024 | 2000 | ₹702 Cr (FY 2025) | Active | |
| Director | 15 Jun 2024 | 2000 | ₹702 Cr (FY 2025) | Active | |
| Director | 23 Jul 2024 | 2011 | ₹49.49 Cr (FY 2026) | Active | |
| Designated Partner | 17 Nov 2022 | 2022 | – | Active | |
| Designated Partner | 12 Jan 2022 | 2022 | – | Active | |
| Designated Partner | 12 Jan 2021 | 2020 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nishant Amilal Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nishant Amilal Shah
Nishant Amilal Shah has 5 years in corporate governance. Holds Designated Partner and Director roles. Currently with 6 companies, including Jackstien International Llp and Affinisio Technologies Llp. Engaged in General Business, Technology and more. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹1,454 Cr; the largest is Thyrocare Technologies Limited at ₹702 Cr (FY 2025).
Nishant Amilal Shah is associated with 6 companies as Designated Partner and Director, including Thyrocare Technologies Limited (₹702 Cr), Thyrocare Technologies Limited (₹702 Cr), Nueclear Healthcare Limited (₹49.49 Cr).
Nishant Amilal Shah has expertise in General Business, Technology and other sectors.
Nishant Amilal Shah has 5 years in corporate governance.
By reported revenue, the largest current company of Nishant Amilal Shah is Thyrocare Technologies Limited, with revenue of ₹702 Cr (FY 2025).
The 3 current companies of Nishant Amilal Shah that report revenue have a combined latest revenue of ₹1,454 Cr.
Nishant Amilal Shah currently holds positions at 6 companies; the 5 largest by reported revenue are Thyrocare Technologies Limited (₹702 Cr), Thyrocare Technologies Limited (₹702 Cr), Nueclear Healthcare Limited (₹49.49 Cr), Work.Is Technologies Llp, Affinisio Technologies Llp.